XAIR 8-K 2026-09-24
Beyond Air, Inc. (XAIR) 8-K dated 2026-09-24 — accession 0001493152-26-044155.
Beyond Air, Inc. (XAIR) is a medical devices company listed on US.
Beyond Air, Inc. filed a 8-K on 2026-09-24. Accession 0001493152-26-044155.
This 8-K covers: Material agreement (Item 1.01), Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported XAIR revenue for 2026-03-31 was $7.7M. Net income was -$33.2M. Revenue was up 107.3% from 2025-03-31 to 2026-03-31. XAIR currently screens at market cap $16.0M.
Not investment advice. The XAIR SEC hub lists recent forms. The stock page is the research view.